Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma
Jack Y. Ghannam, Julian Bryan, Jakob Weiss, Daniel Kovarsky et autres
us, il, ca (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Jack Y. Ghannam, Julian Bryan, Jakob Weiss, Daniel Kovarsky et autres
us, il, ca (code pays fourni par la source)
Jack Y. Ghannam, Julian Bryan, Jakob Weiss, Daniel Kovarsky et autres
us, il, ca (code pays fourni par la source)
Jack Y. Ghannam, Daniel Kovarsky, Laine Marrah, Landon Oetjen et autres
2006 Background: Glioblastoma (GBM) remains uniformly lethal despite standard therapy. An immunosuppressive tumor microenvironment (TME) and limited T cell infiltration pose major barriers to immunotherapy. Personalized neoantigen vaccines offer a strategy to prime tumor-specific T cell responses by targeting patient-specific mutations, driving …
us, il (code pays fourni par la source)
Maxime Meylan, Ye Tian, Lijian Wu, Alexander Ling et autres
Abstract Background: Recurrent glioblastoma (rGBM) remains refractory to immunotherapy due to sparse and suppressed T cell infiltration. We recently reported that survival correlated with immune activation signatures in rGBM patients receiving the oncolytic HSV-1 (oHSV) rQNestin34.5v.2 (CAN-3110). Here, we provide in-situ and …
us, il (code pays fourni par la source)
Maxime Meylan, Ye Tian, Lijian Wu, Alexander Ling et autres
A recent first-in-human clinical trial demonstrated that survival in glioblastoma (GBM) patients following rQNestin34.5v.2 oncolytic virus treatment was associated with immune activation signatures. This study was registered at ClinicalTrials.gov (NCT03152318). Here, we provide in situ evidence of ongoing T cell-mediated cytotoxicity against …
us, il, de (code pays fourni par la source)
Olivier Zerbib, Daniel Kovarsky, Michael Oshrov, lev Shaoul
OBJECTIVE: We report a case of cefazolin-induced coagulopathy, highlighting the importance of maintaining a high index of suspicion for this rare adverse effect of cefazolin. SETTING: Department of intensive care, Rabin Medical Center, Hasharon Hospital, Petach Tikvah, Israel. PATIENT: A patient presented …
il (code pays fourni par la source)
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, Noam Galili Darnell et autres
il (code pays fourni par la source)
Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, Hiroshi Nakashima et autres
Abstract Immunotherapy failures can result from the highly suppressive tumour microenvironment that characterizes aggressive forms of cancer such as recurrent glioblastoma (rGBM) 1,2 . Here we report the results of a first-in-human phase I trial in 41 patients with rGBM who were …
us, il (code pays fourni par la source)
Avishai Gavish, Michael P. H. Tyler, Alissa Greenwald, Rouven Hoefflin et autres
il, de, us, se (code pays fourni par la source)
Olivier Zerbib, Yaniv Hadi, Daniel Kovarsky, Gal Sahaf Levin et autres
Objective: To describe the experience of a multimodal therapeutic approach in a patient with methadone-induced dilated cardiomyopathy who developed recurrent bilateral tension pneumothorax. Setting: Department of Intensive Care. Patient: A patient with methadone-induced cardiomyopathy and severe left ventricular dysfunction who after mechanical …
il (code pays fourni par la source)
Daniel Kovarsky, Adi Shani, Alon Rod, Dan Ciubotaru et autres
The natural history of lumbar disc herniation with radiculopathy is favorable, with 95% of patients expected to be pain-free within 6 months of onset. Despite the favorable prognosis, operative treatment is often chosen by patients unable to "ride out" the radicular episode. …
il (code pays fourni par la source)
Avishai Gavish, Michael P. H. Tyler, Dor Simkin, Daniel Kovarsky et autres
Abstract Each tumor contains malignant cells that differ in genotype, phenotype, and in their interactions with the tumor micro-environment (TME). This results in distinct integrated cellular states that govern intra-tumor heterogeneity (ITH), a central challenge of cancer therapeutics. Dozens of recent studies …
il, us (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic